查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1878101

穿戴式注射器市場－2025-2030年預測

Wearable Injectors Market - Forecasts from 2025 to 2030
出版日期: | 出版商: Knowledge Sourcing Intelligence | 英文 114 Pages | 商品交期: 最快1-2個工作天內

價格
簡介目錄

全球穿戴式注射器市場預計將從 2025 年的 101.48 億美元成長到 2030 年的 250.84 億美元，預測期內複合年成長率為 19.84%。

穿戴式注射器代表了醫療藥物輸送系統的一項重大進步。這些裝置也稱為貼片幫浦或體表輸送系統，直接佩戴在患者身上，旨在以可控、持續的方式輸送藥物。它們特別適用於需要大劑量、高黏度藥物以及需要長期規律給藥的治療方案。透過減少多次且往往痛苦的手動注射，這些裝置提供了一種便捷易用的替代方案，從而提高了患者的依從性和生活品質。

穿戴式注射器的主要提案在於其易於自我給藥、最大限度減少對日常生活的干擾、提高劑量準確性以及預防針刺傷。此外，透過使患者能夠在診所外管理自身健康，可減少就診次數，從而有助於降低整體醫療成本，並賦予患者更大的自主權來管理慢性疾病。

主要市場成長促進因素

全球穿戴式注射器市場的主要成長要素是全球慢性（非傳染性）疾病的日益普遍。癌症、心血管疾病、糖尿病和自體免疫疾病等疾病需要長期且頻繁地用藥。穿戴式注射器在有效控制這些疾病方面發揮著至關重要的作用。它們尤其適用於依規定間隔注射生物製藥和其他複雜的治療藥物，從而避免過量或不足的用藥。這些設備帶來的便利性不僅改善了病患體驗，還透過減少病患因注射而頻繁前往醫院的次數，顯著節省了時間和成本。

隨著疾病負擔的加重，技術進步和意識提升預計也將推動市場成長。日益增強的健康意識和對治療方案的廣泛了解，正在推動對以患者為中心的先進醫療設備的需求。穿戴式注射器順應了這一趨勢，提供了一種隱密且易於操作的治療方案。技術進步也透過高度自動化顯著降低了製造成本，使企業能夠實現規模經濟。這種成本效益使製造商能夠將資金重新投入研發，從而激發創新循環，最終推出更精密、更易於使用的醫療器材。

市場限制

儘管成長前景可觀，但這些設備帶來的環境問題仍是限制市場發展的主要因素。穿戴式注射器通常設計為一次性使用，且由塑膠零件構成。這些設備的大規模應用，加上不當的處置方式，會產生大量的塑膠廢棄物。由於並非所有地區都有完善的醫療廢棄物管理和回收系統，使用過的注射器若處理不當，可能會造成環境風險，因為塑膠需要相當長的時間才能分解。這種生態影響是產業必須透過永續設計和產品報廢管理策略來應對的挑戰。

主要市場趨勢和競爭格局

穿戴式注射器市場活躍度較高，主要廠商紛紛透過策略聯盟、收購和技術升級來鞏固市場地位並拓展產品系列。一個顯著的趨勢是製藥公司與專業醫療器材製造商之間的合作。這些合作旨在共同開發和生產整合式藥物輸送系統，例如 enFuse® 穿戴式注射器，該產品專注於透過便利的居家給藥方式來改善患者體驗。

各公司也正在透過將全面的人體工學融入其開發平台來增強其服務產品，這種方法確保設備對患者來說直覺且安全，從而降低監管核准過程中的風險，並加快新組合產品的上市速度。

策略性收購也是市場格局的關鍵特徵。主要企業正在收購擁有互補技術的公司，例如自動化胰島素輸注系統和藥房自動化解決方案。這些收購旨在建構一個更全面的藥物管理生態系統，涵蓋從急診護理到家庭護理的各個階段，從而提高患者的用藥依從性、安全性和整體治療效果。先進系統的推出，例如與持續血糖監測儀整合的無管自動化胰島素輸注系統，代表持續創新，旨在提供無縫且有效的慢性病管理。

本報告的主要優勢：

  • 深入分析：獲得主要和新興地區的深入市場洞察，重點關注客戶群、政府政策和社會經濟因素、消費者偏好、行業垂直領域和其他細分市場。
  • 競爭格局：了解全球主要參與者的策略舉措，並了解透過正確的策略進入市場的機會。
  • 市場促進因素與未來趨勢：探討影響市場的動態因素和關鍵趨勢及其對未來市場發展的影響。
  • 可操作的建議：利用這些見解，在動態環境中做出策略決策，並開拓新的商機和收入來源。
  • 受眾廣泛：對Start-Ups、研究機構、顧問公司、中小企業和大型企業都很有用且經濟實惠。

企業使用我們的報告做什麼？

產業與市場分析、機會評估、產品需求預測、打入市場策略、地理擴張、資本投資決策、法規結構及影響、新產品開發、競爭情報

報告範圍：

  • 2022年至2024年的歷史數據和2025年至2030年的預測數據
  • 成長機會、挑戰、供應鏈前景、法規結構與趨勢分析
  • 競爭定位、策略和市場佔有率分析
  • 按業務板塊和地區分類的收入成長和預測評估，包括國家/地區
  • 公司概況（策略、產品、財務資訊、關鍵發展等）

穿戴式注射器市場細分：

  • 全球穿戴式注射器市場（按類型分類）
  • 體外注射器
  • 非體注射
  • 全球穿戴式注射器市場（依科技分類）
  • 馬達驅動
  • 擴充電池
  • 彈簧型
  • 旋轉泵型
  • 其他
  • 全球穿戴式注射器市場按應用領域分類
  • 腫瘤學
  • 糖尿病
  • 心血管疾病
  • 自體免疫疾病
  • 其他
  • 全球穿戴式注射器市場（按最終用戶分類）
  • 醫院和診所
  • 門診手術中心
  • 居家照護中心
  • 其他
  • 全球穿戴式注射器市場（按地區分類）
  • 北美洲
  • 美國
  • 加拿大
  • 墨西哥
  • 南美洲
  • 巴西
  • 阿根廷
  • 其他
  • 歐洲
  • 德國
  • 法國
  • 英國
  • 西班牙
  • 其他
  • 中東和非洲
  • 沙烏地阿拉伯
  • 阿拉伯聯合大公國
  • 其他
  • 亞太地區
  • 中國
  • 印度
  • 日本
  • 韓國
  • 印尼
  • 泰國
  • 其他

目錄

第1章執行摘要

第2章 市場概覽

  • 市場概覽
  • 市場定義
  • 調查範圍
  • 市場區隔

第3章 商業情境

  • 市場促進因素
  • 市場限制
  • 市場機遇
  • 波特五力分析
  • 產業價值鏈分析
  • 政策與法規
  • 策略建議

第4章 技術展望

5. 全球穿戴式注射器市場（按類型分類）

  • 介紹
  • 體外注射器
  • 非體注射

6. 全球穿戴式注射器市場（依科技分類）

  • 介紹
  • 馬達驅動
  • 擴充電池
  • 彈簧型
  • 旋轉泵
  • 其他

7. 全球穿戴式注射器市場（按應用分類）

  • 介紹
  • 腫瘤學
  • 糖尿病
  • 心血管疾病
  • 自體免疫疾病
  • 其他

8. 全球穿戴式注射器市場（依最終用戶分類）

  • 介紹
  • 醫院和診所
  • 門診手術中心
  • 居家照護中心
  • 其他

9. 全球穿戴式注射器市場（按地區分類）

  • 介紹
  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 南美洲
    • 巴西
    • 阿根廷
    • 其他
  • 歐洲
    • 德國
    • 法國
    • 英國
    • 西班牙
    • 其他
  • 中東和非洲
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 其他
  • 亞太地區
    • 中國
    • 印度
    • 日本
    • 韓國
    • 印尼
    • 泰國
    • 其他

第10章 競爭格局與分析

  • 主要企業和策略分析
  • 市佔率分析
  • 合併、收購、協議和合作
  • 競爭對手儀錶板

第11章 公司簡介

  • Medtronic
  • Amgen（Acquired by tenebio）
  • Ypsomed
  • Insulet Corporation
  • West Pharmaceutical Services
  • Becton Dickinson And Company
  • Enable Injections
  • United Therapeutics Corporation
  • F. Hoffmann-La Roche AG
  • Johnson & Johnson

第12章附錄

  • 貨幣
  • 先決條件
  • 基準年和預測年時間表
  • 相關人員的主要收益
  • 調查方法
  • 簡稱
簡介目錄
Product Code: KSI061611830

The global wearable injectors market is projected to witness a CAGR of 19.84% during the forecast period to reach a total market size of US$25.084 billion by 2030, increasing from US$10.148 billion in 2025.

Wearable injectors represent a significant advancement in medical drug delivery systems. These devices, also known as patch pumps or on-body delivery systems, are designed to be attached directly to the patient to administer medication in a controlled and sustained manner. They are particularly suited for high-volume drugs, medications with high viscosities, and treatments that require regular administration over extended periods. By reducing the need for multiple, often painful manual injections, these devices offer a convenient and user-friendly alternative that enhances patient compliance and quality of life.

The core value proposition of wearable injectors includes ease of use for self-administration, minimal interference with daily activities, improved dose accuracy, and the prevention of needlestick injuries. Furthermore, by enabling patients to manage their treatments outside of clinical settings, these devices help reduce hospital and clinic visits, contributing to lower overall healthcare costs and providing greater autonomy to individuals managing chronic conditions.

Primary Market Growth Drivers

A primary driver for the global wearable injector market is the increasing prevalence of chronic, or non-communicable, diseases worldwide. Conditions such as cancer, cardiovascular diseases, diabetes, and autoimmune disorders require long-term, often frequent, drug administration. Wearable injectors play a crucial role in managing these diseases effectively. They are especially valuable for delivering biologics and other complex therapeutics at prescribed intervals, thereby eliminating the possibility of over- or under-dosing. The convenience they offer not only improves the patient experience but also generates significant time and cost savings by minimizing the need for frequent medical appointments solely for injections.

Concurrent with the rising disease burden, technological advancement and increasing patient awareness are also anticipated to propel market growth. As individuals become more health-conscious and informed about available treatment options, the demand for advanced, patient-centric medical devices rises. Wearable injectors align with this trend by offering discreet and manageable treatment solutions. Technological progress has also been instrumental in reducing manufacturing costs through advanced automation, enabling companies to achieve economies of scale. This cost efficiency allows manufacturers to reinvest in research and development, fostering a cycle of innovation that leads to more sophisticated and accessible devices.

Market Restraints

Despite the promising growth trajectory, a significant restraint on the market is the environmental concern associated with these devices. Wearable injectors are typically designed for single-use and are constructed with plastic components. The large-scale adoption of these devices, coupled with improper disposal practices, can lead to substantial plastic waste. Since not all regions possess robust medical waste management and recycling systems, the improper handling and disposal of used injectors can pose environmental hazards, as plastics take a considerable time to decompose. This ecological impact presents a challenge that the industry must address through sustainable design and end-of-life management strategies.

Key Market Developments and Competitive Landscape

The wearable injectors market is characterized by dynamic activity, with key players engaging in strategic partnerships, acquisitions, and technological enhancements to strengthen their market position and expand their product portfolios. A prominent trend involves collaborations between pharmaceutical companies and specialized device manufacturers. These partnerships aim to co-develop and manufacture integrated drug delivery systems, such as the enFuse(R) wearable injector, focusing on improving the patient experience through discreet, at-home administration.

Companies are also enhancing their service offerings by integrating comprehensive human factors engineering into their development platforms. This approach de-risks the regulatory approval process and accelerates time-to-market for new combination products by ensuring devices are intuitive and safe for patient use.

Strategic acquisitions are another key feature of the market landscape. Leading companies are acquiring firms with complementary technologies, such as automated insulin delivery systems or pharmacy automation solutions. These acquisitions are aimed at creating more comprehensive medication management ecosystems that span from acute care to home settings, improving medication adherence, patient safety, and overall outcomes. The introduction of advanced systems, including tubeless, automated insulin delivery systems integrated with continuous glucose monitors, exemplifies the ongoing innovation aimed at providing seamless and effective chronic disease management.

Key Benefits of this Report:

  • Insightful Analysis: Gain detailed market insights covering major as well as emerging geographical regions, focusing on customer segments, government policies and socio-economic factors, consumer preferences, industry verticals, and other sub-segments.
  • Competitive Landscape: Understand the strategic maneuvers employed by key players globally to understand possible market penetration with the correct strategy.
  • Market Drivers & Future Trends: Explore the dynamic factors and pivotal market trends and how they will shape future market developments.
  • Actionable Recommendations: Utilize the insights to exercise strategic decisions to uncover new business streams and revenues in a dynamic environment.
  • Caters to a Wide Audience: Beneficial and cost-effective for startups, research institutions, consultants, SMEs, and large enterprises.

What do businesses use our reports for?

Industry and Market Insights, Opportunity Assessment, Product Demand Forecasting, Market Entry Strategy, Geographical Expansion, Capital Investment Decisions, Regulatory Framework & Implications, New Product Development, Competitive Intelligence

Report Coverage:

  • Historical data from 2022 to 2024 & forecast data from 2025 to 2030
  • Growth Opportunities, Challenges, Supply Chain Outlook, Regulatory Framework, and Trend Analysis
  • Competitive Positioning, Strategies, and Market Share Analysis
  • Revenue Growth and Forecast Assessment of segments and regions including countries
  • Company Profiling (Strategies, Products, Financial Information, and Key Developments among others.

Wearable Injectors Market Segmentation:

  • GLOBAL WEARABLE INJECTORS MARKET BY TYPE
  • On-Body Injectors
  • Off-Body Injectors
  • GLOBAL WEARABLE INJECTORS MARKET BY TECHNOLOGY
  • Motor-driven
  • Expanding Battery
  • Spring-based
  • Rotary Pump
  • Others
  • GLOBAL WEARABLE INJECTORS MARKET BY APPLICATION
  • Oncology
  • Diabetes
  • Cardiovascular Disease
  • Autoimmune Disease
  • Others
  • GLOBAL WEARABLE INJECTORS MARKET BY END-USER
  • Hospitals and Clinics
  • Ambulatory Surgery Centres
  • Home Care Centres
  • Other
  • GLOBAL WEARABLE INJECTORS MARKET BY GEOGRAPHY
  • North America
  • USA
  • Canada
  • Mexico
  • South America
  • Brazil
  • Argentina
  • Others
  • Europe
  • Germany
  • France
  • United Kingdom
  • Spain
  • Others
  • Middle East and Africa
  • Saudi Arabia
  • UAE
  • Others
  • Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Indonesia
  • Thailand
  • Others

TABLE OF CONTENTS

1. EXECUTIVE SUMMARY

2. MARKET SNAPSHOT

  • 2.1. Market Overview
  • 2.2. Market Definition
  • 2.3. Scope of the Study

2.4. Market Segmentation

3. BUSINESS LANDSCAPE

  • 3.1. Market Drivers
  • 3.2. Market Restraints
  • 3.3. Market Opportunities
  • 3.4. Porter's Five Forces Analysis
  • 3.5. Industry Value Chain Analysis
  • 3.6. Policies and Regulations
  • 3.7. Strategic Recommendations

4. TECHNOLOGICAL OUTLOOK

5. GLOBAL WEARABLE INJECTORS MARKET BY TYPE

  • 5.1. Introduction
  • 5.2. On-Body Injectors
  • 5.3. Off-Body Injectors

6. GLOBAL WEARABLE INJECTORS MARKET BY TECHNOLOGY

  • 6.1. Introduction
  • 6.2. Motor-driven
  • 6.3. Expanding Battery
  • 6.4. Spring-based
  • 6.5. Rotary Pump
  • 6.6. Others

7. GLOBAL WEARABLE INJECTORS MARKET BY APPLICATION

  • 7.1. Introduction
  • 7.2. Oncology
  • 7.3. Diabetes
  • 7.4. Cardiovascular Disease
  • 7.5. Autoimmune Disease
  • 7.6. Others

8. GLOBAL WEARABLE INJECTORS MARKET BY END-USER

  • 8.1. Introduction
  • 8.2. Hospitals and Clinics
  • 8.3. Ambulatory Surgery Centres
  • 8.4. Home Care Centres
  • 8.5. Other

9. GLOBAL WEARABLE INJECTORS MARKET BY GEOGRAPHY

  • 9.1. Introduction
  • 9.2. North America
    • 9.2.1. USA
    • 9.2.2. Canada
    • 9.2.3. Mexico
  • 9.3. South America
    • 9.3.1. Brazil
    • 9.3.2. Argentina
    • 9.3.3. Others
  • 9.4. Europe
    • 9.4.1. Germany
    • 9.4.2. France
    • 9.4.3. United Kingdom
    • 9.4.4. Spain
    • 9.4.5. Others
  • 9.5. Middle East and Africa
    • 9.5.1. Saudi Arabia
    • 9.5.2. UAE
    • 9.5.3. Others
  • 9.6. Asia Pacific
    • 9.6.1. China
    • 9.6.2. India
    • 9.6.3. Japan
    • 9.6.4. South Korea
    • 9.6.5. Indonesia
    • 9.6.6. Thailand
    • 9.6.7. Others

10. COMPETITIVE ENVIRONMENT AND ANALYSIS

  • 10.1. Major Players and Strategy Analysis
  • 10.2. Market Share Analysis
  • 10.3. Mergers, Acquisitions, Agreements, and Collaborations
  • 10.4. Competitive Dashboard

11. COMPANY PROFILES

  • 11.1. Medtronic
  • 11.2. Amgen (Acquired by tenebio)
  • 11.3. Ypsomed
  • 11.4. Insulet Corporation
  • 11.5. West Pharmaceutical Services
  • 11.6. Becton Dickinson And Company
  • 11.7. Enable Injections
  • 11.8. United Therapeutics Corporation
  • 11.9. F. Hoffmann-La Roche AG
  • 11.10. Johnson & Johnson

12. APPENDIX

  • 12.1. Currency
  • 12.2. Assumptions
  • 12.3. Base and Forecast Years Timeline
  • 12.4. Key Benefits for the Stakeholders
  • 12.5. Research Methodology
  • 12.6. Abbreviations